EP2747562A4 - ESTROGEN RECEPTOR LIGANDS AND METHOD FOR THEIR USE - Google Patents

ESTROGEN RECEPTOR LIGANDS AND METHOD FOR THEIR USE

Info

Publication number
EP2747562A4
EP2747562A4 EP12834287.0A EP12834287A EP2747562A4 EP 2747562 A4 EP2747562 A4 EP 2747562A4 EP 12834287 A EP12834287 A EP 12834287A EP 2747562 A4 EP2747562 A4 EP 2747562A4
Authority
EP
European Patent Office
Prior art keywords
methods
same
estrogen receptor
receptor ligands
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12834287.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2747562A1 (en
Inventor
James Dalton
Mitchell S Steiner
Christopher C Coss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncternal Therapeutics Inc
Original Assignee
GTx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/215,679 external-priority patent/US9427418B2/en
Application filed by GTx Inc filed Critical GTx Inc
Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en
Publication of EP2747562A1 publication Critical patent/EP2747562A1/en
Publication of EP2747562A4 publication Critical patent/EP2747562A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
EP12834287.0A 2011-08-23 2012-08-23 ESTROGEN RECEPTOR LIGANDS AND METHOD FOR THEIR USE Withdrawn EP2747562A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/215,679 US9427418B2 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof
PCT/US2012/052141 WO2013043304A1 (en) 2009-02-23 2012-08-23 Estrogen receptor ligands and methods of use thereof

Publications (2)

Publication Number Publication Date
EP2747562A1 EP2747562A1 (en) 2014-07-02
EP2747562A4 true EP2747562A4 (en) 2015-05-06

Family

ID=48444651

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12834287.0A Withdrawn EP2747562A4 (en) 2011-08-23 2012-08-23 ESTROGEN RECEPTOR LIGANDS AND METHOD FOR THEIR USE

Country Status (10)

Country Link
EP (1) EP2747562A4 (https=)
JP (1) JP2014524479A (https=)
KR (1) KR20140064906A (https=)
CN (1) CN103957706A (https=)
AU (1) AU2012312902B2 (https=)
CA (1) CA2845890A1 (https=)
IL (1) IL231070A0 (https=)
IN (1) IN2014DN01959A (https=)
MX (1) MX2014002105A (https=)
RU (1) RU2014111060A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020535171A (ja) * 2017-09-27 2020-12-03 ターグイミューン セラピューティクス アーゲー 去勢抵抗性前立腺癌
TWI840496B (zh) * 2019-01-30 2024-05-01 美商艾瑞岡醫藥公司 用於治療轉移性去勢敏感性前列腺癌之抗雄性激素
MX2021009119A (es) * 2019-02-01 2022-01-18 Fond Per Listituto Oncologico Di Ricerca Ior Metodos de tratamiento contra el cancer de prostata resistente a la castracion.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007062230A2 (en) * 2005-11-28 2007-05-31 Gtx, Inc. Nuclear receptor binding agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
WO2010096801A1 (en) * 2009-02-23 2010-08-26 Gtx, Inc. Estrogen receptor ligands and methods of use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007062230A2 (en) * 2005-11-28 2007-05-31 Gtx, Inc. Nuclear receptor binding agents

Also Published As

Publication number Publication date
IL231070A0 (en) 2014-03-31
AU2012312902B2 (en) 2016-03-17
JP2014524479A (ja) 2014-09-22
KR20140064906A (ko) 2014-05-28
MX2014002105A (es) 2014-09-25
AU2012312902A1 (en) 2013-05-23
RU2014111060A (ru) 2015-09-27
CN103957706A (zh) 2014-07-30
EP2747562A1 (en) 2014-07-02
CA2845890A1 (en) 2013-03-28
IN2014DN01959A (https=) 2015-05-15

Similar Documents

Publication Publication Date Title
IL284407B (en) Opioid receptor ligands and methods for their use and preparation
EP2598630A4 (en) NEW BACTERIA AND METHOD FOR THEIR USE
EP2563813A4 (en) ANTI-C5A ANTIBODIES AND METHOD OF USE THEREOF
EP2606670A4 (en) METHOD FOR POINT ASSOCIATION FOR COOPERATIVE MULTIPORT TRANSMISSION
EP2593098A4 (en) METHOD AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY
EP2794928A4 (en) COMPOSITIONS AND METHODS FOR DETECTING ANALYTES
EP2935628A4 (en) COMPOSITIONS AND METHODS FOR APTAMER SCREENING
EP2809262A4 (en) IMPLANT DEVICES AND METHODS FOR ANEURYSMA
EP2579828A4 (en) METHOD AND DEVICE FOR INHIBITING SCARCING
EP2538785A4 (en) PROCESS FOR THE SYNTHESIS OF DIARYLTHIOHYDANTOIN AND DIARYLHYDANTOINE COMPOUNDS
EP2252631A4 (en) BCR COMPLEX-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
EP2726493A4 (en) METHOD AND COMPOSITIONS FOR SELECTIVELY REGULATING A PROTEIN EXPRESSION
EP2542576A4 (en) METHOD FOR SCREENING ANTIBODIES
EP2848072A4 (en) METHOD AND DEVICES FOR IMPROVED TIMELY RATE FOR INTEGRATED HETEROGENIC MULTI-RAT NETWORKS
EP2731617A4 (en) LIPID-BASED PSA COMPOSITIONS, METHOD FOR THEIR INSULATION AND USE METHOD THEREFOR
EP2521777A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF GLIOBLASTOMES (GBM)
EP2750509A4 (en) METHOD FOR GENERATING CARDIOMYOCYTES
EP2773358A4 (en) COMPOSITIONS AND METHODS FOR BLOOD-TREATMENT
FR2955747B1 (fr) Moyen de reglage pour vetement
EP2760887A4 (en) COMPOSITIONS AND METHODS OF HEMOSTASE MODULATION
EP2756161A4 (en) METHOD OF USE OF OLEHOLDING LIQUIDS FOR FINAL OPERATIONS
EP2909181A4 (en) PKM2 MODULATORS AND METHOD FOR THEIR USE
EP2890342A4 (en) ELECTRICAL DEVICE AND METHOD AND DEVICE FOR POSITIONING AND IMPLANTING COMPONENTS THEREOF
EP2931280A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING CNKSR1
EP2250189A4 (en) GYLCOPEPTIDES AND METHOD FOR THEIR PREPARATION AND USE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140305

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150408

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/00 20060101ALI20150331BHEP

Ipc: A61K 45/06 20060101ALI20150331BHEP

Ipc: A61K 31/167 20060101AFI20150331BHEP

Ipc: A61K 31/137 20060101ALI20150331BHEP

Ipc: A61K 31/4453 20060101ALI20150331BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180301